Adaptimmune Therapeutics PLC (ADAP) Retained Earnings (Accumulated Deficit) USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Adaptimmune Therapeutics PLC quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2014 to 2024.
  • Adaptimmune Therapeutics PLC Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$1.07 B, a 18% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$1.07 B -$163 M -18% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$1.02 B -$114 M -12.5% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 -$975 M -$95.2 M -10.8% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$930 M -$91 M -10.9% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$908 M -$114 M -14.4% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 -$909 M -$165 M -22.2% Dec 31, 2022 10-K 2024-03-06
Q3 2022 -$880 M -$175 M -24.8% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$839 M -$176 M -26.6% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$794 M -$171 M -27.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 -$744 M -$158 M -27% Dec 31, 2021 10-K 2023-03-06
Q3 2021 -$705 M -$156 M -28.4% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 -$663 M -$149 M -29% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 -$624 M -$140 M -28.9% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 -$586 M -$130 M -28.6% Dec 31, 2020 10-K 2022-03-14
Q3 2020 -$549 M -$123 M -28.8% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$514 M -$127 M -32.7% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 -$484 M -$138 M -39.9% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 -$456 M -$137 M -43.1% Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$426 M -$144 M -51% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 -$387 M -$99.4 M -34.6% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 -$346 M -$102 M -41.7% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 -$318 M -$86.9 M -37.5% Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$282 M -$78 M -38.1% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 -$288 M -$84.1 M -41.3% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 -$244 M -$60.8 M -33.2% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 -$232 M -$70.1 M -43.4% Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$204 M -$58.3 M -39.9% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 -$203 M -$75.9 M -59.5% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 -$183 M -$77.8 M -73.7% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 -$161 M -$71.6 M -79.6% Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$146 M Sep 30, 2016 10-Q 2016-11-10
Q2 2016 -$128 M -$60.7 M -90.7% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 -$105 M Mar 31, 2016 10-Q 2016-05-12
Q4 2015 -$89.9 M Dec 31, 2015 10-K 2017-03-13
Q2 2015 -$66.9 M -$36.8 M -122% Jun 30, 2015 10-K 2017-03-13
Q2 2014 -$30.1 M Jun 30, 2014 8-K 2016-07-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.